Financials
- Market Capitalization 8.1 B
- Employee 691
- Founded 2014
- CEO Rich Adcock
- Website www.immunitybio.com
- Headquarter Delaware, United States
- FIGI BBG007T9DYW9
- Industry 생명공학
총매출
순이익
주당 순이익(기본 EPS)
총부채
잉여 현금 흐름
현금 및 현금성 자산
주가수익비율
-9.02
주가매출액비율
51.72
Related tickers
| # | 이름 | 가격 | 24h % | 7d % | 1M % | 1Y % | 마켓 캡 | 이전 7일 | |
|---|---|---|---|---|---|---|---|---|---|
| 1030 | PCVX Vaxcyte, Inc. - Common Stock | 56.73 USD | +0.93% | -3.37% | +14.44% | +34.11% | 8.19 B USD | ||
| 1032 | IMVT Immunovant, Inc. - Common Stock | 39.89 USD | +2.89% | -1.04% | +20.11% | +107.65% | 8.19 B USD | ||
| 1057 | KNSA Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares | 61.69 USD | -0.47% | -4.74% | +18.18% | +55.61% | 7.71 B USD | ||
| 1077 | RYTM Rhythm Pharmaceuticals, Inc. - Common Stock | 109.62 USD | -0.31% | -4.09% | +20.54% | -0.63% | 7.51 B USD |